Targeted mass spectrometry for monitoring of neural
differentiation

J 2021

Targeted mass spectrometry for monitoring of neural differentiation

SUCHA, Rita, Martina KUBICKOVA, Jakub CERVENKA, Marian HRUSKA-PLOCHAN, Dáša BOHAČIAKOVÁ et. al.

Basic information

Original name

Targeted mass spectrometry for monitoring of neural differentiation

Authors

SUCHA, Rita (203 Czech Republic), Martina KUBICKOVA (203 Czech Republic), Jakub CERVENKA (203 Czech Republic), Marian HRUSKA-PLOCHAN, Dáša BOHAČIAKOVÁ (703 Slovakia, belonging to the institution), Katerina KEPKOVA VODICKOVA (203 Czech Republic), Tereza NOVAKOVA (203 Czech Republic), Katerina BUDKOVA (203 Czech Republic), Andrej SUSOR, Martin MARSALA (203 Czech Republic), Jan MOTLIK (203 Czech Republic), Hana KOVAROVA (203 Czech Republic) and Petr VODICKA (203 Czech Republic, guarantor)

Edition

Biology Open, CAMBRIDGE, COMPANY BIOLOGISTS LTD, 2021, 2046-6390

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10602 Biology , Evolutionary biology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 2.643

RIV identification code

RIV/00216224:14110/21:00119648

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1242/bio.058727

UT WoS

000692170900005

Keywords in English

Neural stem cell; Neural differentiation; Selected reaction monitoring; Mass spectrometry; Cell line characterization; Protein marker

Abstract

V originále

Human multipotent neural stem cells could effectively be used for the treatment of a variety of neurological disorders. However, a defining signature of neural stem cell lines that would be expandable, non-tumorigenic, and differentiate into desirable neuronal/glial phenotype after in vivo grafting is not yet defined. Employing a mass spectrometry approach, based on selected reaction monitoring, we tested a panel of well-described culture conditions, and measured levels of protein markers routinely used to probe neural differentiation, i.e. POU5F1 (OCT4), SOX2, NES, DCX, TUBB3, MAP2, S100B, GFAP, GALC, and OLIG1. Our multiplexed assay enabled us to simultaneously identify the presence of pluripotent, multipotent, and lineage committed neural cells, thus representing a powerful tool to optimize novel and highly specific propagation and differentiation protocols. The multiplexing capacity of this method permits the addition of other newly identified cell type-specific markers to further increase the specificity and quantitative accuracy in detecting targeted cell populations. Such an expandable assay may gain the advantage over traditional antibody-based assays, and represents a method of choice for quality control of neural stem cell lines intended for clinical use.

Links

GJ15-18316Y, research and development project

Name: Úloha microRNA v řízení buněčného dělení a diferenciace lidských embryonálních kmenových buněk do neurálních kmenových buněk. (Acronym: miRNA v diferenciaci lidských EK buněk)

Investor: Czech Science Foundation

Citovat

SUCHA, Rita, Martina KUBICKOVA, Jakub CERVENKA, Marian HRUSKA-PLOCHAN, Dáša BOHAČIAKOVÁ, Katerina KEPKOVA VODICKOVA, Tereza NOVAKOVA, Katerina BUDKOVA, Andrej SUSOR, Martin MARSALA, Jan MOTLIK, Hana KOVAROVA and Petr VODICKA. Targeted mass spectrometry for monitoring of neural differentiation. Biology Open. CAMBRIDGE: COMPANY BIOLOGISTS LTD, 2021, vol. 10, No 8, p. 1-13. ISSN 2046-6390. Available from: https://dx.doi.org/10.1242/bio.058727.

@article{1834297,
   author = {Sucha, Rita and Kubickova, Martina and Cervenka, Jakub and HruskaandPlochan, Marian and Bohačiaková, Dáša and Kepkova Vodickova, Katerina and Novakova, Tereza and Budkova, Katerina and Susor, Andrej and Marsala, Martin and Motlik, Jan and Kovarova, Hana and Vodicka, Petr},
   article_location = {CAMBRIDGE},
   article_number = {8},
   doi = {http://dx.doi.org/10.1242/bio.058727},
   keywords = {Neural stem cell; Neural differentiation; Selected reaction monitoring; Mass spectrometry; Cell line characterization; Protein marker},
   language = {eng},
   issn = {2046-6390},
   journal = {Biology Open},
   title = {Targeted mass spectrometry for monitoring of neural differentiation},
   url = {https://journals.biologists.com/bio/article/10/8/bio058727/271174/Targeted-mass-spectrometry-for-monitoring-of},
   volume = {10},
   year = {2021}
}

TY  - JOUR
ID  - 1834297
AU  - Sucha, Rita - Kubickova, Martina - Cervenka, Jakub - Hruska-Plochan, Marian - Bohačiaková, Dáša - Kepkova Vodickova, Katerina - Novakova, Tereza - Budkova, Katerina - Susor, Andrej - Marsala, Martin - Motlik, Jan - Kovarova, Hana - Vodicka, Petr
PY  - 2021
TI  - Targeted mass spectrometry for monitoring of neural differentiation
JF  - Biology Open
VL  - 10
IS  - 8
SP  - 1-13
EP  - 1-13
PB  - COMPANY BIOLOGISTS LTD
SN  - 20466390
KW  - Neural stem cell
KW  - Neural differentiation
KW  - Selected reaction monitoring
KW  - Mass spectrometry
KW  - Cell line characterization
KW  - Protein marker
UR  - https://journals.biologists.com/bio/article/10/8/bio058727/271174/Targeted-mass-spectrometry-for-monitoring-of
N2  - Human multipotent neural stem cells could effectively be used for the treatment of a variety of neurological disorders. However, a defining signature of neural stem cell lines that would be expandable, non-tumorigenic, and differentiate into desirable neuronal/glial phenotype after in vivo grafting is not yet defined. Employing a mass spectrometry approach, based on selected reaction monitoring, we tested a panel of well-described culture conditions, and measured levels of protein markers routinely used to probe neural differentiation, i.e. POU5F1 (OCT4), SOX2, NES, DCX, TUBB3, MAP2, S100B, GFAP, GALC, and OLIG1. Our multiplexed assay enabled us to simultaneously identify the presence of pluripotent, multipotent, and lineage committed neural cells, thus representing a powerful tool to optimize novel and highly specific propagation and differentiation protocols. The multiplexing capacity of this method permits the addition of other newly identified cell type-specific markers to further increase the specificity and quantitative accuracy in detecting targeted cell populations. Such an expandable assay may gain the advantage over traditional antibody-based assays, and represents a method of choice for quality control of neural stem cell lines intended for clinical use.
ER  -

SUCHA, Rita, Martina KUBICKOVA, Jakub CERVENKA, Marian HRUSKA-PLOCHAN, Dáša BOHAČIAKOVÁ, Katerina KEPKOVA VODICKOVA, Tereza NOVAKOVA, Katerina BUDKOVA, Andrej SUSOR, Martin MARSALA, Jan MOTLIK, Hana KOVAROVA and Petr VODICKA. Targeted mass spectrometry for monitoring of neural differentiation. \textit{Biology Open}. CAMBRIDGE: COMPANY BIOLOGISTS LTD, 2021, vol.~10, No~8, p.~1-13. ISSN~2046-6390. Available from: https://dx.doi.org/10.1242/bio.058727.

Detailed Information on Publication Record